- Home
- SRPT vs FULTP Comparison
SRPT vs FULTP Comparison
Compare SRPT & FULTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SRPT | FULTP |
|---|---|---|
| Founded | 1980 | N/A |
| Country | United States | United States |
| Employees | N/A | 3400 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | N/A |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | SRPT | FULTP |
|---|---|---|
| Price | $20.03 | $18.69 |
| Analyst Decision | Hold | |
| Analyst Count | 28 | 0 |
| Target Price | ★ $25.40 | N/A |
| AVG Volume (30 Days) | ★ 3.2M | 8.9K |
| Earning Date | 05-05-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,198,237,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.58 | N/A |
| 52 Week Low | $10.42 | $17.31 |
| 52 Week High | $67.47 | $20.83 |
Technical Indicators
Market Signals| Indicator | SRPT | FULTP |
|---|---|---|
| Relative Strength Index (RSI) | 56.41 | 41.98 |
| Support Level | $16.38 | $18.30 |
| Resistance Level | $23.01 | $19.26 |
| Average True Range (ATR) | 1.20 | 0.38 |
| MACD | 0.62 | -0.03 |
| Stochastic Oscillator | 49.54 | 25.61 |
Price Performance
Historical ComparisonAbout SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.
About FULTP Fulton Financial Corporation Depositary Shares Each Representing a 1/40th Interest in a Share of Fixed Rate Non-Cumulative Perpetual Preferred Stock Series A
Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.